Case Reports
doi: 10.1136/jnnp.40.11.1109.
4-aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome
- PMID: 202680
- PMCID: PMC492909
- DOI: 10.1136/jnnp.40.11.1109
Item in Clipboard
Case Reports
4-aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome
J Neurol Neurosurg Psychiatry.
1977 Nov.
Abstract
A 67 year old man with the myasthenic syndrome associated with small cell bronchogenic carcinoma was treated with a new drug, 4-aminopyridine. The muscle weakness showed marked improvement and electrophysiological examinations demonstrated restoration of neuromuscular transmission.
Similar articles
-
The influence of local cooling on neuromuscular transmission in the myasthenic syndrome of Eaton and Lambert.J Neurol. 1977 Dec 13;217(2):95-102. doi: 10.1007/BF00312922. J Neurol. 1977. PMID: 75262
-
Neuromuscular transmission in nude mice bearing oat cell tumors from Lambert-Eaton myasthenic syndrome.Muscle Nerve. 1982;5(9S):S39-45. Muscle Nerve. 1982. PMID: 6302495
-
Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage-gated calcium channel antibody.Muscle Nerve. 1994 Sep;17(9):1073-5. doi: 10.1002/mus.880170919. Muscle Nerve. 1994. PMID: 8065398 No abstract available.
-
Lambert-Eaton myasthenic syndrome in small cell lung cancer: nursing implications.Oncol Nurs Forum. 1994 May;21(4):677-83; quiz 684-5. Oncol Nurs Forum. 1994. PMID: 8047466 Review.
-
[Lambert-Eaton myasthenic syndrome].Ryoikibetsu Shokogun Shirizu. 2000;(31):56-8. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11269163 Review. Japanese. No abstract available.
Cited by
-
The use of 4-aminopyridine (fampridine) in demyelinating disorders.CNS Drug Rev. 2004 Winter;10(4):295-316. doi: 10.1111/j.1527-3458.2004.tb00029.x. CNS Drug Rev. 2004. PMID: 15592580 Free PMC article. Review.
-
Cancer-associated myasthenic (Eaton-Lambert) syndrome: distribution of abnormality and effect of treatment.J Neurol Neurosurg Psychiatry. 1984 Aug;47(8):806-12. doi: 10.1136/jnnp.47.8.806. J Neurol Neurosurg Psychiatry. 1984. PMID: 6088701 Free PMC article.
-
3,4-Diaminopyridine, an orphan drug, in the symptomatic treatment of Lambert-Eaton myasthenic syndrome.Pflugers Arch. 1996;431(6 Suppl 2):R295-6. doi: 10.1007/BF02346385. Pflugers Arch. 1996. PMID: 8739381 Review.
-
Lack of effect of 4-aminopyridine on choreic movements.J Neurol Neurosurg Psychiatry. 1982 Mar;45(3):274-5. doi: 10.1136/jnnp.45.3.274. J Neurol Neurosurg Psychiatry. 1982. PMID: 6211524 Free PMC article. No abstract available.
-
Treatment for Lambert-Eaton myasthenic syndrome.Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD003279. doi: 10.1002/14651858.CD003279.pub3. Cochrane Database Syst Rev. 2011. PMID: 21328260 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
